BDN

Brandywine is a Philadelphia/Austin-centric office REIT caught in a genuine secular squeeze, and management doesn't hide it: the MD&A states that inflation, high interest rates and 'changes in work patterns, including remote working arrangements' have driven 'negative lease absorption,' 'increased borrowing costs,' 'lower occupancy' and 'downward pressures on asset valuations,' plus 'recent difficulties in asset dispositions at acceptable prices.' The numbers corroborate this: FY2025 revenue fell 4.2% to $484M (the third straight year of decline off the $515M FY2023 peak), operating income was halved to $26.7M, and the trust posted its third consecutive large net loss (-$178M, -$1.03 diluted EPS). Core occupancy of 88.3% and shrinking net rentable square feet (11.3M vs 11.9M a year ago) tell you the portfolio is being pruned faster than it is being re-leased.

For a REIT, the headline net loss overstates the damage — it is largely non-cash, absorbing $176M of D&A and impairments. The truer gauge, operating cash flow, is still positive at $117M, roughly a 20% cash yield on the $563M market cap, and the stock trades below its $4.56/share book value. That is the bull case: you are paying a discounted price for a portfolio of Class-A Philadelphia CBD assets (Cira Center, 1717 Arch, FMC Tower) that are mostly 90%+ leased.